Parkinson's Disease and Related Disorders Part II
Handbook of Clinical Neurology (Series Editors: Aminoff, Boller and Swaab)
- William Koller, MD, PhD, Department of Neurology, UNC-Chapel Hill, NC, USA
- Eldad Melamed, MD, Department of Neurology, Rabin Medical Center, Petaq Tiqva, Israel
Through a high-level presentation of new research regarding these diseases, this handbook will give clinicians and neuroscientists alike a better understanding of the dramatic pharmacological advances made in the management of Parkinsonâs disease, and the profound observations that have altered the medical communityâs approach to other degenerative disorders of the nervous system.
Practitioners, researchers, and medical personnel will gain exciting insights into recent developments that form the basis for new therapeutic strategies and management protocols for the various neurological disorders that present with Parkinsonism.
Neurologists and research neuroscientists
- Published: June 2007
- Imprint: ELSEVIER
- ISBN: 978-0-444-52893-3
Table of ContentsSection 5: Treatment of Parkinson's disease
Physical therapy in Parkinsonâs disease. Neuroprotection in Parkinsonâs disease: clinical trials. Levodopa. Dopamine agonists. Monoamine oxidase A and B inhibitors in Parkinsonâs disease. Anticholinergic medications. Antiglutamatergic drugs in the treatment of Parkinsonâs disease. Investigational drugs. The importance of patients groups and collaboration
Section 6: Complications of therapy
Motor and non-motor fluctuations. Levodopa-induced dyskinesias in Parkinsonâs disease. Treatment induced mental changes in Parkinsonâs disease.
Section 7 Surgical treatment
Ablative surgery for the treatment of Parkinsonâs disease. Deep brain stimulation. Transplantation. Gene therapy approaches for the treatment of Parkinsonâs disease.
Section 8: Other parkinsonian disease syndromes
Multiple system atrophy. Progressive supranuclear palsy. Corticobasal degeneration. Infectious basis to the pathogenesis of Parkinsonâs disease. Toxic causes of Parkinsonâs disease. Drug induced parkinsonism. Vascular parkinsonism. Old age and Parkinsonâs disease. Other degenerative processes. Hydrocephalus and structural lesions. Calcification of the basal ganglia. Trauma and Parkinsonâs disease. Psychogenic parkinsonism. Parkinsonism and dystonia. Dementia with Lewy bodies. Myoclonus and parkinsonism.